$11.11
1.93% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US0231112063
Symbol
AMRN
Sector
Industry

Amarin Corporation Plc Sponsored ADR Stock price

$11.11
+1.56 16.34% 1M
+1.22 12.36% 6M
+1.41 14.54% YTD
-6.49 36.87% 1Y
-17.29 60.88% 3Y
-138.09 92.55% 5Y
-27.49 71.22% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.21 1.93%
ISIN
US0231112063
Symbol
AMRN
Sector
Industry

Key metrics

Market capitalization $230.18m
Enterprise Value $-43.97m
P/E (TTM) P/E ratio negative
EV/Sales (TTM) EV/Sales -0.21
P/S ratio (TTM) P/S ratio 1.07
P/B ratio (TTM) P/B ratio 0.49
Revenue growth (TTM) Revenue growth -22.93%
Revenue (TTM) Revenue $214.21m
EBIT (operating result TTM) EBIT $-94.81m
Cash position $282.09m
EPS (TTM) EPS $-4.27
P/E forward negative
P/S forward 1.30
EV/Sales forward negative
Short interest 3.32%
Show more

Is Amarin Corporation Plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Amarin Corporation Plc Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Amarin Corporation Plc Sponsored ADR forecast:

1x Hold
33%
2x Sell
67%

Analyst Opinions

3 Analysts have issued a Amarin Corporation Plc Sponsored ADR forecast:

Hold
33%
Sell
67%

Financial data from Amarin Corporation Plc Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
214 214
23% 23%
100%
- Direct Costs 142 142
8% 8%
66%
72 72
51% 51%
34%
- Selling and Administrative Expenses 146 146
18% 18%
68%
- Research and Development Expense 18 18
8% 8%
8%
-92 -92
84% 84%
-43%
- Depreciation and Amortization 2.99 2.99
1% 1%
1%
EBIT (Operating Income) EBIT -95 -95
80% 80%
-44%
Net Profit -88 -88
67% 67%
-41%

In millions USD.

Don't miss a Thing! We will send you all news about Amarin Corporation Plc Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Amarin Corporation Plc Sponsored ADR Stock News

Neutral
Seeking Alpha
14 days ago
Amarin Corporation plc (NASDAQ:AMRN ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Mark Marmur - Vice President of Corporate Communications and Investor Relations Aaron Berg - President and Chief Executive Officer Peter Fishman - Vice President and Global Controller Steven Ketchum - Executive Vice President, President of R&D and Chief Scientific Officer Conferenc...
Neutral
GlobeNewsWire
21 days ago
-- Nasdaq Compliance Follows ADS Ratio Change to Secure Company's Public Listing -- -- Amarin Remains Focused on Maximizing the Global Value of VASCEPA/VAZKEPA –
Neutral
GlobeNewsWire
22 days ago
DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin's senior management team to discuss its first quarter 2025 results followed by Q&A on Wednesday, May 7th, 2025, at 8:00 a.m. ET.
More Amarin Corporation Plc Sponsored ADR News

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Head office United Kingdom
CEO Aaron Berg
Employees 275
Founded 1989
Website www.amarincorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today